×

RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN FOR THE TREATMENT OF INFLAMMATORY DISORDERS

  • US 20140228301A1
  • Filed: 12/19/2012
  • Published: 08/14/2014
  • Est. Priority Date: 12/19/2011
  • Status: Abandoned Application
First Claim
Patent Images

1. A composition comprising alpha-1-antitrypsin (AAT), wherein the AAT is recombinantly produced.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×